Chief Executive Officer
CurrentNovilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices. Our company is currently focused on the pharmaceutical bioreactor market. That concentration is based on strong monetary and regulatory interest from pharmaceutical companies to improve the production quality of a specific drug category. Novilytic also has both current and developing products for both medical device and other bioreactor technologies. Watch for us while we grow!